Article

Hepatitis C virus seroprevalence among haemodialysis patients, sickle cell patients and blood donors at a tertiary hospital in Yaounde, Cameroon

DOI: 10.1080/23120053.2017.1349065
Author(s): Therese NdomgueDepartment of Microbiology/Immunology, Cameroon, Michel KengneDepartment of Microbiology/Immunology, Cameroon, Patrick Achiangia NjukengDepartment of Plant Biology, Cameroon, Valentine Ngum NdzeMetabiota Cameroon, Cameroon, Damien Nota AnongDepartment of Microbiology and Parasitology, Cameroon, Tracy Madimabi MasebeDepartment of Life and Consumer Sciences, South Africa, Ubald TamoufeMetabiota Cameroon, Cameroon, Anastasia Yenban BongajumService for the prevention of mother-to-child transmission of HIV (PMTCT), Cameroon, Daniel Ter GoonDepartment of Nursing Sciences, South Africa, Julius Mbekem NwobegahayMilitary Health Research Center (CRESAR), Cameroon

Abstract

Background: Hepatitis C virus (HCV) infection is a serious health care problem in haemodialysis patients, sickle cell patients and blood donation in Africa. However, there is a paucity of information about this in Cameroon. This study presents the prevalence of antibodies to HCV among haemodialysis patients, sickle cell patients and blood donors at the Yaounde University Teaching Hospital, Cameroon.

Get new issue alerts for Southern African Journal of Infectious Diseases